Prefrontal cortex, hippocampus, and basolateral amygdala plasticity in a rat model of autism spectrum

Area of Science:

• Neuroscience
• Developmental Biology
• Toxicology

Background:

• Autistic spectrum disorder (ASD) is a complex neurodevelopmental condition.
• Prenatal exposure to certain substances, like valproic acid (VPA), is a known risk factor for ASD.
• Understanding the specific neuroanatomical effects of prenatal VPA exposure is crucial for identifying potential biomarkers and therapeutic targets.

Purpose of the Study:

• To investigate the impact of prenatal valproic acid (VPA) administration on the anatomical development of key brain regions in a rat model of autistic spectrum disorder.
• To assess these anatomical changes at different developmental stages: immediately after weaning (PD21), prepubertal (PD35), and postpubertal (PD70).

Main Methods:

• Valproic acid (VPA) was administered (500 mg/kg) at embryonic day 12.5 in a rat model.
• Quantitative analysis was performed on the prefrontal cortex, hippocampus, and basolateral amygdala at PD21, PD35, and PD70.
• Measurements included cortical thickness and regional size.

Main Results:

• Prenatal VPA exposure led to reduced size in the cingulate 1 area of the prefrontal cortex and CA1 of the dorsal hippocampus across all studied ages.
• The basolateral amygdala showed reduced size at prepubertal (PD35) and postpubertal (PD70) ages in VPA-exposed rats.
• Reduced thickness was observed in the prelimbic region of the prefrontal cortex at PD35, while the infralimbic region remained unaffected.

Conclusions:

• Prenatal VPA exposure differentially affects the anatomical parameters of cortical limbic regions.
• These structural alterations in the prefrontal cortex, hippocampus, and amygdala may have significant implications for understanding the neurobiology of autistic spectrum disorder.
• The findings highlight the vulnerability of specific brain regions to prenatal insults during critical developmental periods.